Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > EBIT

Apellis Pharmaceuticals Inc EBIT Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly EBIT from 2017 to 2018. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Apellis Pharmaceuticals Inc EBIT for the quarter ending December 12, 2018 was $-37m a 42.37% decrease of -16m year over year
  • Apellis Pharmaceuticals Inc EBIT for the last 12 months ending December 12, 2018 was $-128m a 50.63% decrease of -65m year over year
  • Apellis Pharmaceuticals Inc Annual EBIT for 2018 was $-128m a 60.31% decrease of -77m from 2017
  • Apellis Pharmaceuticals Inc Annual EBIT for 2017 was $-51m a 46.26% decrease of -23m from 2016
  • Apellis Pharmaceuticals Inc Annual EBIT for 2016 was $-27m a 26.37% decrease of -7m from 2015
Other Income Statement Metrics:
  • Apellis Pharmaceuticals Inc EBITDA for the quarter ending December 12, 2018 was $-37m a 42.92% decrease of -16m year over year
  • Apellis Pharmaceuticals Inc Net Income for the quarter ending December 12, 2018 was $-36m a 40.38% decrease of -15m year over year
View Chart On Koyfin

Quarterly APLS EBIT Data

12/2018$-37m
09/2018$-36m
06/2018$-33m
03/2018$-21m
12/2017$-18m
09/2017$-12m
06/2017$-12m

Annual APLS EBIT Data

2018$-128m
2017$-51m
2016$-27m
2015$-20m